Another approach might be the use of combination therapies that target tumor proliferation while also promoting immune infiltration, such as BRAF-targeted therapies or oncolytic viruses that have been demonstrated to replicate preferentially within cells with defective IFN signaling [9]. Here, BRAF is linked to neoplasm.